share_log

RBC Capital Reiterates Outperform on Boston Scientific, Maintains $70 Price Target

Benzinga ·  Feb 5 10:06

RBC Capital analyst Shagun Singh reiterates Boston Scientific (NYSE:BSX) with a Outperform and maintains $70 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment